CLINICAL_TRIALS
trial_result
· 2023-03-24
Clinical Trial Update: OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules [Phase 2]
Summary
Phase 2 trial update for OTL38 injection used for intraoperative imaging of folate receptor-positive lung nodules; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: On Target Laboratories, LLC | Conditions: Lung Neoplasms, Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-03-24